Abstract
Overexpression of the EGF receptor in breast cancer correlates with poor prognosis and failure on endocrine therapy for both ER−/EGFR+ and ER+/EGFR+ tumors, suggesting a role for EGFR in the progression to hormone independence. The identification of specific DNase I hypersensitive site patterns for the EGFR gene in ER+ vs. ER− cells implicates regions of the EGFR first intron in up-regulation of EGFR, while estrogen regulation studies indicate the involvement of a repressor(s) in the maintenance of low levels of EGFR. Based on these findings, a multi-step model is proposed for the progression of breast cancer from a hormone-dependent, ER+/EGFR- phenotype to an aggressive, hormone-independent, ER−/EGFR+ stage.
Similar content being viewed by others
References
Dickson RB, Johnson MD, El-Ashry D, Shi YE, Bano M, Zugmaier G, Ziff B, Lippman ME. Chrysogelos S: Breast cancer: Influence of endocrine hormones, growth factors and genetic alterations. In: Yang SS (ed) Underlying Molecular, Cellular and Immunological Factors in Age Related Cancers. Plenum Press, NY. 1991
Cohen S, Ushiro H, Stoscheck C, Chinkers M: A native 170000 epidermal growth factor receptor-kinase complex from shed membrane vesicles. J Biol Chem 257: 1523–1531, 1982
Downward J, Yarden Y, Mayes E, Scarce G, Totty N, Stockwell P, Ullrich A, Schlessinger J, Waterfield MD: Close similarity of epidermal growth factor receptor and v-erbB oncogene protein sequences. Nature 307: 521–527, 1984
DiMarco E, Pierce JH, Fleming TP, Kraus MH, Molloy CJ, Aaronson SA, DiFiore PP: Autocrine interaction between TGFα and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. Oncogene 4: 831–839, 1990
Derynck R, Goddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH: Synthesis of mRNAs for TGF-α and β and epidermal growth factor receptor by human tumors. Cancer Res 47: 707–712, 1987
Gullick WJ: Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. British Med Bulletin 47: 87–98, 1991
Nicholson S, Sainsbury JRC, Halcrow P, Chambers P, Farndon JR, Harris AL: Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer. Lancet i: 182–184, 1989
Nicholson S, Richard J, Sainsbury C, Halcrow P, Kelly P, Angus B, Wright C, Henry J, Farndon JR, Harris AL: Epidermal growth factor receptor: results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup. Br J Cancer 63: 146–150, 1991
Bolufer P, Miralles F, Rodriguez A, Vasquez C, Lluch A, Garcia-Conde J, Olmos T: Epidermal growth factor receptor in human breast cancer: correlation with cytosolic and nuclear estrogen receptors and with biological and histological tumor characteristics. Eur J Cancer 26: 283–290, 1990
Nicholson S, Halcrow P, Sainsbury JRC, Angus B, Chambers P, Farndon JR, Harris AL: Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer. Br J Cancer 58: 810–814, 1988
Fitzpatrick SL, Brightwell J, Wittliff J, Barrows GH, Schultz GS: Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen and progestin receptor levels. Cancer Res 44: 3448–3453, 1984
Sainsbury JRC, Farndon JR, Sherbert GV, Harris AL: Epidermal growth factor receptors and oestrogen receptors in human breast cancers. Lancet i: 364–366, 1985
Koenders PG, Beex LVAM, Geurts-Moespot A, Heuvel JJTM, Kienhuis CBM, Benraad TJ: Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers. Cancer Res 51: 4544–4548, 1991
Velu TJ, Bequinot L, Vass MC, Willingham MC, Merlino GT, Pastan I, Lowy D: Epidermal growth factor-dependent transformation by a human EGF receptor proto-oncogene. Science 238: 1408–1410, 1987
DiFiore P, Pierce J, Fleming T, Hazon R, Ullrich A, King CR, Schlessinger J, Aaronson S: Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH3T3 cells. Cell 51: 1063–1070, 1987
Shankar V, Cardellio F, Kim N, Derynck R, Liscia DS, Merlo G, Langton BC, Sheer D, Callahan R, Bassin RH, Lippman ME, Hynes N, Salomon DS: Transformation of normal mouse mammary epithelial cells following transfection with a human transforming growth factor alpha cDNA. Mol Carcinog 2: 1–11, 1989
Rosenthal A, Lindquist PB, Bringman TS, Goeddel DV, Derynck R: Expression in rat fibroblasts of human transforming growth factor-α cDNA results in transformation. Cell 46: 301–309, 1986
Ennis BW, Valverius E, Bates SE, Lippman ME, Bellot F, Kris R, Schlessinger J, Masui H, Goldberg A, Mendelsohn J, Dickson RB: Anti EGF-receptor antibodies inhibit the autocrine stimulated growth of MDA-MB-468 human breast cancer cells. Mol Endocrinol 3: 1830–1838, 1989
Bates SE, Valverius EM, Ennis BW, Bronzert DA, Sheridan JP, Stampfer MR, Mendelsohn J, Lippman ME, Dickson RB: Expression of the transforming growth factor-α/epidermal growth factor receptor pathway in normal human breast epithelial cells. Endocrinol 126: 596–607, 1990
Valverius EM, Ciardiello F, Heldin NE, Blondel B, Merlo G, Smith G, Stampfer MR, Lippman ME, Dickson RB, Salomon DS: Stromal influences on transformation of human mammary epithelial cells overexpressing c-myc and SV40T. J Cell Physiol 145: 207–216, 1990
Agthoven TV, Agthoven TLAV, Portengen H, Foekers JA, Dorsse LCJ: Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells. Cancer Res 52: 5082–5088, 1992
Dickson RB, McManaway ME, Lippman ME: Estrogen induced factors of breast cancer cells partially replace estrogen to promote tumor growth. Science 232: 1540–1543, 1986
Xu YH, Richert N, Ito S, Merlino GT, Pastan I: Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines. Proc Natl Acad Sci USA 81: 7308–7312, 1984
King CR, Kraus MH, Williams LT, Merlino GT, Pastan IH, Aaronson SA: Human tumor cell lines with EGF receptor gene amplification in the absence of aberrant sized mRNAs. Nucl Acids Res 13: 8477–8486, 1985
Davidson NE, Gelmann EP, Lippman ME, Dickson RB: Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol Endocrinol 1: 216–223, 1987
Kudlow JE, Cheung C-YM, Bjorge JD: Epidermal growth factor stimulates the synthesis of its own receptor in a human breast cancer cell line. J Biol Chem 261: 4134–4138, 1985
Bjorge JD, Kudlow JE: Epidermal growth factor receptor synthesis is stimulated by phorbol ester and epidermal growth factor. J Biol Chem 262: 6615–6622, 1987
Clark AJL, Ishii S, Richert N, Merlino GT, Pastan I: Epidermal growth factor regulates the expression of its own receptor. Proc Natl Acad Sci USA 82: 8374–8378, 1986
Fernandez-Pol JA, Hamilton PD, Klos DJ: Transcriptional regulation of proto-oncogene expression by epidermal growth factor, transforming growth factor β1, and triiodothyronine in MDA-468 cells. J Biol Chem 264: 4151–4156, 1989
Fernandez-Pol JA, Klos DJ, Hamilton PD: Modulation of transforming growth factor alpha-dependent expression of epidermal growth factor receptor gene by transforming growth factor beta, triiodothyronine, and retinoic acid. J Cell Biochem 41: 159–170, 1989
Mukku VR: Regulation of epidermal growth factor receptor levels by thyroid hormone. J Biol Chem 259: 6543–6547, 1984
Hudson LG, Santon JB, Glass CK, Gill GN: Ligand-activated thyroid hormone and retinoic acid receptors inhibit growth factor receptor promoter expression. Cell 62: 1165–1175, 1990
Kesavan P, Mukhopadhayay S, Murphy S, Rengaraju M, Lazar MA, Das M: Thyroid hormone decreases the expression of epidermal growth factor receptor. J Biol Chem 266: 10282–10286, 1991
Thompson KL, Rosner MR: Regulation of epidermal growth factor receptor gene expression by retinoic acid and epidermal growth factor. J Biol Chem 264: 3230–3234, 1989
Hudson LG, Santon JB, Gill GN: Regulation of epidermal growth factor receptor gene expression. Mol Endocrinol 3: 400–408, 1989
Zheng Z-S, Polakowska R, Johnson A, Goldsmith LA: Transcriptional control of epidermal growth factor receptor by retinoic acid. Cell Growth Differ 3: 225–232, 1992
Saceda M, Knabbe C, Dickson RB, Lippman ME, Bronzert D, Lindsey RK, Gottardis MM, Martin MB: Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by TPA. J Biol Chem 266: 17809–17814, 1991
deFazio A, Chiew Y-E, Donoghue C, Lee CSL, Sutherland RL: Effect of sodium butyrate on estrogen receptor and epidermal growth factor receptor gene expression in human breast cancer cell lines. J Biol Chem 267: 18008–18012, 1992
Hudson LG, Thompson KL, Xu J, Gill GN: Identification and characterization of a regulated promoter element in the epidermal growth factor receptor gene. Proc Natl Acad Sci USA 87: 7536–7540, 1990
Lingham RB, Stancel GM, Loose-Mitchell DS: Estrogen regulation of epidermal growth factor receptor messenger ribonucleic acid. Mol Endocrinol 2: 230–235, 1988
Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH: Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309: 418–425, 1984
Johnson AC, Ishii S, Jinno Y, Pastan I, Merlino GT: Epidermal growth factor receptor gene promoter. Deletion analysis and identification of nuclear protein binding sites. J Biol Chem 263: 5693–5699, 1988
Kageyama R, Merlino GT, Pastan I: Epidermal growth factor (EGF) receptor gene transcription. Requirement for Sp1 and an EGF receptor-specific factor. J Biol Chem 263: 6329–6336, 1988
Kageyama R, Merlino GT, Pastan I: A transcription factor active on the epidermal growth factor receptor gene. Proc Natl Acad Sci USA 85: 5016–5020, 1988
Merlino GT, Johnson AC, Kageyama R, Pastan I: Isolation and characterization of DNA-binding factors regulating transcription of the EGF receptor proto-oncogene. In: Lippman ME, Dickson RB (eds) Growth Regulation of Cancer II: UCLA Symposia on Molecular and Cellular Biology. New Series, Vol. 115. Alan R Liss, Inc., New York, 1989
Ishii S, Xu Y-H, Stratton RH, Roe BA, Merlino GT, Pastan I: Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene. Proc Natl Acad Sci USA 82: 4920–4924, 1985
Kageyama R, Pastan I: Molecular cloning and characterization of a human DNA binding factor that represses transcription. Cell 59: 815–825, 1989
Gross DS, Garrard WT: Nuclease hypersensitive sites in chromatin. Annu Rev Biochem 57: 159–197, 1988
Chrysogelos SA: Regulation of the EGFR gene in breast cancer cell lines: chromatin structure analysis reveals the involvement of intron 1 sequences. J Cell Biochem 17A: 69, 1993
Chrysogelos SA: Chromatin structure of the EGFR gene suggests a role for intron 1 sequences in its regulation in breast cancer cells. Nucleic Acids Res 21: 5736–5741, 1993
Vickers PJ, Dickson RB, Shoemaker R, Cowan KH: A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to anti-estrogens and hormone-independent growthin vivo. Mol Endocrinol 2: 886–892, 1988
Filmus J, Pollak MN, Cailleau R, Buick RN: MDA-468, a breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem Biophys Res Commun 128: 898–905, 1985
Kraus MH, Popescu NC, Amsbaugh SC, King CR: EMBO J 6: 605–610, 1984
Pauli U, Chrysogelos S, Stein J, Stein G: Native genomic blotting: high resolution mapping of DNase I hypersensitive sites and protein-DNA interactions. Proc Natl Acad Sci USA 85: 16–20, 1988
Pauli U, Chrysogelos S, Stein J, Stein G: Native genomic blotting: a novel approach to mapping of DNase I hypersensitive sites and protein-DNA interactions at high resolution. Biotechniques 6: 142–146, 1988
Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS: Phenol red in tissue culture media is a weak estrogen: Implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83: 2496–2500, 1986
Page MJ, Field JK, Everett NP, Green CD: Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7. Cancer Res 43: 1244–1249, 1983
Haley JD, Waterfield MD: Contributory effects ofde novo transcription and premature transcript termination in the regulation of human epidermal growth factor receptor proto-oncogene RNA synthesis. J Biol Chem 266: 1746–1753, 1991
Maekawa T, Imamoto F, Merlino GT, Pastan I, Ishii S: Cooperative function of two separate enhancers of the human epidermal growth factor receptor proto-oncogene. J Biol Chem 264: 5488–5494, 1989
Murphey J, Chrysogelos S: Intron 1 elements are involved in EGFR gene regulation in breast cancer cells. (Abstract) J Cell Biochem, in press, 1994
Mukku VR, Stancel GM: Regulation of epidermal growth factor receptor by estrogen. J Biol Chem 260: 9820–9824, 1985
Chrysogelos SA, Yarden RI: Estrogen regulation of EGF receptor mRNA in human breast cancer cells. (Abstract # K309) J Cell Biochem 18B: in press, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chrysogelos, S.A., Yarden, R.I., Lauber, A.H. et al. Mechanisms of EGF receptor regulation in breast cancer cells. Breast Cancer Res Tr 31, 227–236 (1994). https://doi.org/10.1007/BF00666156
Issue Date:
DOI: https://doi.org/10.1007/BF00666156